Clinical Trials
59 trialsHigh Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Parametric PET of Genitourinary Cancer
University of California, Davis
ICI-PICK
Indiana University
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Health Gatherings - For Your Health After Cancer
University of Miami
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lipac Oncology LLC
SOGUGCOVID
Spanish Oncology Genito-Urinary Group
TasteSPICIER
University Medical Center Groningen
MOM
Inova Health Care Services
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Sharp HealthCare
REMEDY
University Health Network, Toronto
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
BANN
University Medical Center Groningen
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning
Milton S. Hershey Medical Center
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
Steba Biotech S.A.
The Target Urine VOCs Biosensor for Genitourinary Malignancy Detection
Suranaree University of Technology
A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Aragon Pharmaceuticals, Inc.
STEP
Kaiser Permanente
Evaluation of NanoDoceĀ® in Participants With Urothelial Carcinoma
NanOlogy, LLC
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Mayo Clinic
G-DEFINER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis
City of Hope Medical Center
Avatar
University of Campinas, Brazil
Evaluation of Ocoxin-ViusidĀ® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)
Samsung Medical Center
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Women's College Hospital
PROfind
Advanced Accelerator Applications
ESKO
Tampere University Hospital
Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
M.D. Anderson Cancer Center
PREDICARE
LEO Pharma
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
Virginia Commonwealth University
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
IGF Oncology, LLC
Trial of NanoPacĀ® Focal Therapy in Subjects With Prostate Cancer
NanOlogy, LLC
ChemoRenCan
University Hospital, Bordeaux
PCM301
Steba Biotech S.A.
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Belgian Gynaecological Oncology Group
Personal Web Page In Clinical Trial Participant Education
Dana-Farber Cancer Institute
PAMCap
University of Texas Southwestern Medical Center
A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients
University of Toronto
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
Novartis
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Dendreon
AIR
Region Skane
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients
University of Michigan
INTORACT
Pfizer
Study of WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
PCM304
Steba Biotech S.A.
Assessing the Patient Experience in Cancer Care
Mayo Clinic
JASINT1
Pierre Fabre Medicament
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
M.D. Anderson Cancer Center